KBLM - Blockbuster year for SPACs an easier way to go public than a traditional IPOs

FY2020 till date has seen 127 SPAC IPOs, which collectively raised over $48.5B in proceeds, much more than the past ten years combined.Going public via a SPACs is a cost-effective way of doing an M&A deal in weeks instead of months, and its proving to be an especially attractive vehicle for biotech companies by providing ready access to capital and much greater public visibility.Followed by successful SPAC merger of Immatics (IMTX) with Arya Sciences Acquisition, Immunovant (IMVT) with Health Sciences Acquisitions Corporation (in 2019), AdaptHealth Holdings (AHCO) with DFB Healthcare Acquisitions (in 2019) and currently MultiPlan with Churchill Capital Corp III (CCXXU), expectations are high on 180 Life Sciences merger with KBL Merger (KBLM) before year ends.DraftKings (DKNG) and Skillz (FEAC) were large and successful SPACs of the year.

For further details see:

Blockbuster year for SPACs, an easier way to go public than a traditional IPOs